盆腔器官脱垂修复术前静脉注射对乙酰氨基酚:一项随机对照试验
这项双盲安慰剂对照多中心试验将接受脱垂手术的女性随机分为术前静脉注射对乙酰氨基酚1000 mg组或生理盐水组,按手术路径分层。结果显示术前静脉注射对乙酰氨基酚未降低术后24小时疼痛评分或阿片类药物用量,对满意度或生活质量也无影响。
要点
- 术前静脉注射对乙酰氨基酚未降低术后24小时疼痛评分。
- 术前静脉注射对乙酰氨基酚未减少24小时阿片类药物用量。
- 除尿潴留外,满意度、生活质量及副作用无差异。
核心结论
- 在接受脱垂修复的女性中,术前静脉注射对乙酰氨基酚未降低疼痛评分或阿片类药物使用,且对患者满意度或生活质量无影响。
- 本研究不支持单独常规使用预防性静脉注射对乙酰氨基酚。
研究设计与样本
- 双盲安慰剂对照多中心试验,将接受脱垂手术的女性随机分为静脉注射对乙酰氨基酚1000 mg组或术前生理盐水组,按手术路径(腹腔镜或阴道)分层。
- 2014年至2017年间入组204名女性,分析其中162名的主要结局数据。
- 女性平均(±SD)年龄66±10岁,主要为白人(96%)和绝经后(96%)。
- 101名接受阴道手术的女性中52名使用对乙酰氨基酚,101名接受腹腔镜手术的女性中50名使用对乙酰氨基酚。
主要发现
- 术后24小时疼痛评分较基线的平均变化在对乙酰氨基酚组与安慰剂组之间总体及按手术路径均无差异(总体25±26 vs 21±24 mm;阴道29±28 vs 21±23 mm;腹腔镜20±26 vs 21±25 mm)。
- 24小时吗啡毫克当量阿片类药物用量无差异(总体38±25 vs 40±25 mg;阴道32±24 vs 33±25 mg;腹腔镜45±24 vs 47±24 mg)。
- 除尿潴留外,患者满意度、生活质量或副作用未见差异。
临床怎么用
- 本研究不支持单独常规使用预防性静脉注射对乙酰氨基酚。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the effect of preoperative intravenous (IV) acetaminophen compared with placebo on pain scores after pelvic organ prolapse surgery. METHODS: This double-blind placebo-controlled multicenter trial randomized women undergoing prolapse surgery to IV acetaminophen (1,000 mg) or preoperative saline stratified by surgical route (laparoscopic or vaginal). The primary outcome was the change from baseline in patient-reported visual analog scale pain scores at 24 hours after surgery. Secondary outcomes included narcotic use measured in morphine milligram equivalents, satisfaction and quality of life (QOL) using validated questionnaires on postoperative days 1 and 7, and overall side effects. RESULTS: Between 2014 and 2017, 204 women were enrolled and primary-outcome data from 162 were analyzed. Women had a mean (±SD) age of 66±10 years, were predominantly Caucasian (96%) and postmenopausal (96%). Acetaminophen was administered to 52 of the 101 women undergoing vaginal surgery, and 50 of the 101 women undergoing laparoscopy. There were no overall or route of surgery differences in mean change from baseline pain scores at 24 hours between acetaminophen and placebo (overall 25±26 vs 21±24 mm; vaginal 29±28 vs 21±23 mm; laparoscopic 20±26 vs 21±25 mm). There were no differences in 24-hour morphine milligram equivalent narcotic use (overall 38±25 vs 40±25 mg; vaginal 32±24 vs 33±25 mg; laparoscopic 45±24 vs 47±24 mg). No differences were seen in patient satisfaction, QOL, or side effects, except for urinary retention. CONCLUSION: In women undergoing prolapse repair, preoperative IV acetaminophen did not reduce pain scores or opioid use and had no effect on patient satisfaction or QOL. Routine use of preemptive IV acetaminophen alone is not supported by this study. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT02155738.
引用
- Turner LC, Zyczynski HM, Shepherd JP, et al. Intravenous Acetaminophen Before Pelvic Organ Prolapse Repair: A Randomized Controlled Trial. Obstet Gynecol. 2019. PMID: 30741813. doi:10.1097/AOG.0000000000003102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。